Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BERENICE phase II trial of benznidazole regimens in chronic Chagas disease
2016-003789-21Phase 2Active
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of benznidazole in American trypanosomiasis (CD), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Efficacy. Started Nov 2016; status: active.
02
Drugs
benznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on 2016-003789-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003789-21.